{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:35:12Z","timestamp":1778877312823,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-2-2184"],"award-info":[{"award-number":["2024-2-2184"]}]},{"name":"National Key Research and Development Program of Ministry of Science and Technology","award":["2023YFC2308100"],"award-info":[{"award-number":["2023YFC2308100"]}]},{"name":"High-level public health technical talents construction project of Beijing Municipal Health Commission","award":["Academic Leader -02-14"],"award-info":[{"award-number":["Academic Leader -02-14"]}]},{"name":"Capital Clinical Diagnostic Techniques and Translational Application Projects","award":["Z211100002921059"],"award-info":[{"award-number":["Z211100002921059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02853-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:51:30Z","timestamp":1752137490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Shan","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongshan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfa","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"2","key":"2853_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"issue":"4","key":"2853_CR2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800","journal-title":"Hepatology"},{"issue":"6","key":"2853_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3760\/cma.j.issn.1674-2397.2022.06.001","volume":"15","author":"Chinese Society of Hepatology, Chinese Society of Infectious Diseases","year":"2022","unstructured":"Chinese Society of Hepatology, Chinese Society of Infectious Diseases. Guidelines for the prevention and treatment of chronic hepatitis B (2022 version). Chin J Clin Infect Dis. 2022;15(6):401\u201327. https:\/\/doi.org\/10.3760\/cma.j.issn.1674-2397.2022.06.001","journal-title":"Chin J Clin Infect Dis"},{"key":"2853_CR4","doi-asserted-by":"publisher","first-page":"1035923","DOI":"10.3389\/fimmu.2022.1035923","volume":"13","author":"S Ren","year":"2022","unstructured":"Ren S, Wang W, Lu J, et al. Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone. Front Immunol. 2022;13:1035923. https:\/\/doi.org\/10.3389\/fimmu.2022.1035923","journal-title":"Front Immunol"},{"issue":"3","key":"2853_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu J, Liang W, Jing W, et al. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230\u20138. https:\/\/doi.org\/10.2471\/BLT.18.219469","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2853_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","volume":"50","author":"MF Yuen","year":"2009","unstructured":"Yuen MF, Tanaka Y, Fong DYT, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50(1):80\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2008.07.023","journal-title":"J Hepatol"},{"issue":"9","key":"2853_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/liv.13142","volume":"36","author":"E Raffetti","year":"2016","unstructured":"Raffetti E, Fattovich G, Donato F. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis. Liver Int. 2016;36(9):1239\u201351. https:\/\/doi.org\/10.1111\/liv.13142","journal-title":"Liver Int"},{"issue":"3","key":"2853_CR8","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1111\/jvh.70008","volume":"32","author":"A Eilard","year":"2025","unstructured":"Eilard A, Ringlander J, Andersson ME, et al. Long-term outcome of chronic hepatitis B-histological score and viral genotype are important predictors of hepatocellular carcinoma. J Viral Hepat. 2025;32(3):e70008. https:\/\/doi.org\/10.1111\/jvh.70008","journal-title":"J Viral Hepat"},{"issue":"5 Suppl","key":"2853_CR9","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/hep.22884","volume":"49","author":"CJ Chen","year":"2009","unstructured":"Chen CJ, Yang HI, Iloeje UH, et al. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology. 2009;49(5 Suppl):S72\u201384. https:\/\/doi.org\/10.1002\/hep.22884","journal-title":"Hepatology"},{"issue":"3","key":"2853_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/hep.32231","volume":"75","author":"NA Terrault","year":"2022","unstructured":"Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA. Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort. Hepatology. 2022;75(3):709\u201323. https:\/\/doi.org\/10.1002\/hep.32231","journal-title":"Hepatology"},{"issue":"12","key":"2853_CR11","first-page":"711","volume":"37","author":"Chinese Society of Infectious Diseases, Chinese Society of Hepatology","year":"2019","unstructured":"Chinese Society of Infectious Diseases, Chinese Society of Hepatology. Guidelines for the prevention and treatment of chronic hepatitis B (2019 version). Chin J Infect Dis. 2019;37(12):711\u201336.","journal-title":"Chin J Infect Dis"},{"key":"2853_CR12","doi-asserted-by":"publisher","unstructured":"Cornberg M et al. authors. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.018. European Association for the Study of the Liver.","DOI":"10.1016\/j.jhep.2025.03.018"},{"issue":"6","key":"2853_CR13","first-page":"850","volume":"9","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Peng H, Liu X, Wang H, Du J, Luo X, Ren H, Hu P. Chronic hepatitis B infection with low level viremia correlates with the progression of the liver disease. J Clin Transl Hepatol. 2021;9(6):850\u20139. Epub 2021 May 7. Erratum in: J Clin Transl Hepatol.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"2853_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3350\/cmh.2024.0252","volume":"30","author":"GA Kim","year":"2024","unstructured":"Kim GA, Choi SW, Han S, Lim YS. Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B. Clin Mol Hepatol. 2024;30(4):793\u2013806. https:\/\/doi.org\/10.3350\/cmh.2024.0252. Epub 2024 Jul 19.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"2853_CR15","doi-asserted-by":"publisher","first-page":"2339944","DOI":"10.1080\/22221751.2024.2339944","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang J, Zhu L, Zhang S, et al. Clinical outcomes of treatment-na\u00efve hbeag negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA[J]. Emerg Microbes Infect. 2024;13(1):2339944.","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"2853_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/gutjnl-2023-330225","volume":"73","author":"WM Choi","year":"2024","unstructured":"Choi WM, Kim GA, Choi J, Choi GH, Lee YB, Sinn DH, Lim YS. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B. Gut. 2024;73(4):649\u201358. https:\/\/doi.org\/10.1136\/gutjnl-2023-330225","journal-title":"Gut"},{"issue":"1","key":"2853_CR17","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.dld.2025.01.127","volume":"57","author":"M Rossi","year":"2025","unstructured":"Rossi M, Vecchi A, Guerrieri F, Levrero M, Boni C. Characterization of transcriptional and functional CD8 T cell heterogeneity to design individualized correction strategies for chronic HBV infection. Dig Liver Dis. 2025;57(1):S68.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"2853_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","volume":"67","author":"TC Yip","year":"2017","unstructured":"Yip TC, Chan HL, Wong VW, Tse YK, Lam KL, Wong GL. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2017;67(5):902\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.019. Epub 2017 Jun 24.","journal-title":"J Hepatol"},{"issue":"1","key":"2853_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10238-024-01394-0","volume":"24","author":"R Ma","year":"2024","unstructured":"Ma R, Sun JH, Wang YY. The role of transforming growth factor-\u03b2 (TGF-\u03b2) in the formation of exhausted CD8\u2009+\u2009T cells. Clin Exp Med. 2024;24(1):128. https:\/\/doi.org\/10.1007\/s10238-024-01394-0","journal-title":"Clin Exp Med"},{"issue":"12","key":"2853_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/pathogens13121100","volume":"13","author":"W He","year":"2024","unstructured":"He W, Zheng Z, Zhao Q, Zhang R, Zheng H. Targeting HBV CccDNA levels: key to achieving complete cure of chronic hepatitis B. Pathogens. 2024;13(12):1100.","journal-title":"Pathogens"},{"key":"2853_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13578-024-01298-2","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Wang F, Geng Z, et al. HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma. Cell Biosci. 2024;14:116.","journal-title":"Cell Biosci"},{"issue":"18","key":"2853_CR22","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.3390\/ijms22189858","volume":"22","author":"D Zhang","year":"2021","unstructured":"Zhang D, Guo S, Schrodi SJ. Mechanisms of DNA methylation in virus-host interaction in hepatitis B infection: pathogenesis and oncogenetic properties. Int J Mol Sci. 2021;22(18):9858.","journal-title":"Int J Mol Sci"},{"key":"2853_CR23","doi-asserted-by":"crossref","unstructured":"Getachew A, Hussain M, Huang X. Toll-like receptor 2 signaling in liver pathophysiology. Life Sciences. 2021;284:119941.","DOI":"10.1016\/j.lfs.2021.119941"},{"issue":"26","key":"2853_CR24","doi-asserted-by":"publisher","first-page":"eadn5228","DOI":"10.1126\/sciadv.adn5228","volume":"10","author":"S Khanal","year":"2024","unstructured":"Khanal S, Liu Y, Bamidele AO, et al. Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis. Sci Adv. 2024;10(26):eadn5228.","journal-title":"Sci Adv"},{"key":"2853_CR25","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00109-023-02360-1","volume":"101","author":"A Salminen","year":"2023","unstructured":"Salminen A. The role of immunosuppressive myofibroblasts in the aging process and age-related diseases. J Mol Med. 2023;101:1169\u201389.","journal-title":"J Mol Med"},{"key":"2853_CR26","volume-title":"WHO-HIV-2016.06-chi","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. WHO-HIV-2016.06-chi. Geneva: WHO; 2016."},{"issue":"5","key":"2853_CR27","first-page":"698","volume":"48","author":"C Jiang","year":"2023","unstructured":"Jiang C, Liu J, Li R, et al. Clinicopathologic features of liver inflammation and fibrosis in 310 patients with chronic hepatitis B. J Cent South Univ (Med Sci). 2023;48(5):698\u2013706.","journal-title":"J Cent South Univ (Med Sci)"},{"issue":"7","key":"2853_CR28","first-page":"746","volume":"30","author":"H Ni","year":"2022","unstructured":"Ni H, Ji H, Li K, et al. Analysis of liver pathologic inflammatory fibrosis and influencing factors in 721 patients with ALT-normal chronic hepatitis B. Chin J Hepatol. 2022;30(7):746\u201351.","journal-title":"Chin J Hepatol"},{"issue":"1","key":"2853_CR29","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.dld.2024.01.079","volume":"56","author":"F Cinque","year":"2024","unstructured":"Cinque F, Milic J, Renzetti S. The effect of metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in virus-related liver disease: a multicenter longitudinal study. Dig Liver Dis. 2024;56(1):S47\u20138.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"2853_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.gastro.2022.10.008","volume":"164","author":"D Yardeni","year":"2023","unstructured":"Yardeni D, Chang KM, Ghany MG. Current best practice in hepatitis B management and understanding long-term prospects for cure. Gastroenterology. 2023;164(1):42\u2013e606. https:\/\/doi.org\/10.1053\/j.gastro.2022.10.008","journal-title":"Gastroenterology"},{"key":"2853_CR31","doi-asserted-by":"crossref","unstructured":"Zhenhuan CY, Liu,Lina, Ma et al. A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha[J]. Hepatology. 2017;66(4):1058\u20131066.","DOI":"10.1002\/hep.29213"},{"key":"2853_CR32","doi-asserted-by":"crossref","unstructured":"Wang ASX,Junfeng, Lu et al. Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: a meta-analysis[J]. J Viral Hepat. 2021;28(4):601\u2013612.","DOI":"10.1111\/jvh.13471"},{"issue":"4","key":"2853_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.21037\/hbsn-21-228","volume":"10","author":"Y Midorikawa","year":"2021","unstructured":"Midorikawa Y, Tatsuno K, Moriyama M. Genome-wide analysis of hepatitis B virus integration in hepatocellular carcinoma: insights from next generation sequencing. Hepatobiliary Surg Nutr. 2021;10(4):548\u201352. https:\/\/doi.org\/10.21037\/hbsn-21-228","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2853_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41586-024-08466-x","volume":"639","author":"M Reina-Campos","year":"2025","unstructured":"Reina-Campos M, Monell A, Ferry A, et al. Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted. Nature. 2025;639:483\u201392. https:\/\/doi.org\/10.1038\/s41586-024-08466-x","journal-title":"Nature"},{"key":"2853_CR35","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1038\/s41598-017-05242-y","volume":"7","author":"D Mu","year":"2017","unstructured":"Mu D, Yuan FC, Chen Y, et al. Baseline value of intrahepatic HBV DNA over CccDNA predicts patient\u2019s response to interferon therapy. Sci Rep. 2017;7:5937. https:\/\/doi.org\/10.1038\/s41598-017-05242-y","journal-title":"Sci Rep"},{"issue":"14","key":"2853_CR36","doi-asserted-by":"publisher","first-page":"e3026","DOI":"10.1097\/MD.0000000000003026","volume":"95","author":"YE Chon","year":"2016","unstructured":"Chon YE, Kim DJ, Kim SG, et al. An observational, multicenter, cohort study evaluating the antiviral efficacy and safety in Korean patients with chronic hepatitis B receiving pegylated interferon-alpha 2a (pegasys): TRACES study. Med (Baltim). 2016;95(14):e3026. https:\/\/doi.org\/10.1097\/MD.0000000000003026","journal-title":"Med (Baltim)"},{"issue":"1","key":"2853_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12876-019-0981-5","volume":"19","author":"J Sun","year":"2019","unstructured":"Sun J, Ding H, Chen G, et al. Sustained serological and complete responses in HBeAg-positive patients treated with peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterol. 2019;19(1):65. https:\/\/doi.org\/10.1186\/s12876-019-0981-5","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"2853_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cgh.2019.04.020","volume":"18","author":"Y Wu","year":"2020","unstructured":"Wu Y, Liu Y, Lu J, et al. Durability of interferon-induced hepatitis B surface antigen seroclearance. Clin Gastroenterol Hepatol. 2020;18(2):514\u2013e5162. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2853_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.surg.2020.11.015","volume":"169","author":"GK Fusai","year":"2021","unstructured":"Fusai GK, Tamburrino D, Partelli S, et al. Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors: an international multicenter comparative study. Surgery. 2021;169(5):1093\u2013101. https:\/\/doi.org\/10.1016\/j.surg.2020.11.015","journal-title":"Surgery"},{"issue":"10","key":"2853_CR40","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/j.cgh.2023.01.035","volume":"21","author":"JK Liu","year":"2023","unstructured":"Liu JK, Kam LY, Huang DQ. Racial and ethnic disparities in characteristics and care patterns of chronic hepatitis B patients in the United States. Clin Gastroenterol Hepatol. 2023;21(10):2606\u2013e26157. https:\/\/doi.org\/10.1016\/j.cgh.2023.01.035","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02853-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02853-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02853-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:04:29Z","timestamp":1757217869000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02853-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2853"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02853-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6729956\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Beijing Youan Hospital, Capital Medical University (Approval Code: [2022]159), in accordance with the 1975 Helsinki Declaration (revised 1983). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (retrospective analysis of anonymized data).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}